C-Tri to speed up R&D for new drugs.

C-Tri Co., a bio-tech venture company (www.c-tri.com) plans to have a temporary shareholder's meeting on Aug. 23 to ratify the M&A with Chirogene after taking over Chirogene Co., another bio-tech venture company having a technology for the photo active compound synthesis. The merger has made in an exchange of stocks between two companies, then the total equity being expanded to 3,937 million wo...